These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1825795)

  • 1. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome.
    Cossarizza A; Ortolani C; Forti E; Montagnani G; Paganelli R; Zannotti M; Marini M; Monti D; Franceschi C
    Blood; 1991 Mar; 77(6):1263-70. PubMed ID: 1825795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers.
    Cossarizza A; Monti D; Montagnani G; Ortolani C; Masi M; Zannotti M; Franceschi C
    Am J Med Genet Suppl; 1990; 7():213-8. PubMed ID: 2149950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD16- CD56+ natural killer cells after bone marrow transplantation.
    Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
    Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's syndrome.
    Nair MP; Schwartz SA
    Clin Immunol Immunopathol; 1984 Dec; 33(3):412-24. PubMed ID: 6209046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition by neomycin.
    Orago AS; Facer CA
    Clin Exp Immunol; 1991 Oct; 86(1):22-9. PubMed ID: 1833100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological abnormalities in patients with chronic fatigue syndrome.
    Tirelli U; Marotta G; Improta S; Pinto A
    Scand J Immunol; 1994 Dec; 40(6):601-8. PubMed ID: 7997849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of lymphocyte beta-adrenergic receptor in Down's syndrome: a biological marker of a neuroimmune deficit.
    Morale MC; Batticane N; Cioni M; Marchetti B
    J Neuroimmunol; 1992 Jun; 38(3):185-98. PubMed ID: 1318320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians.
    Sansoni P; Cossarizza A; Brianti V; Fagnoni F; Snelli G; Monti D; Marcato A; Passeri G; Ortolani C; Forti E
    Blood; 1993 Nov; 82(9):2767-73. PubMed ID: 8219229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome.
    Cetiner S; Demirhan O; Inal TC; Tastemir D; Sertdemir Y
    Int J Immunogenet; 2010 Aug; 37(4):233-7. PubMed ID: 20477881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.
    Maccario R; Ugazio AG; Nespoli L; Alberini C; Montagna D; Porta F; Bonetti F; Burgio GR
    Clin Exp Immunol; 1984 Jul; 57(1):220-6. PubMed ID: 6235075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatally diagnosable differences in the cellular immunity of fetuses with Down's and Edwards' syndrome.
    Zizka Z; Calda P; Fait T; Haakova L; Kvasnicka J; Viskova H
    Fetal Diagn Ther; 2006; 21(6):510-4. PubMed ID: 16969005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAK activity is inducible in blood mononuclear cells from human fetus.
    Cossarizza A; Monti D; Dagna-Bricarelli F; Montagnani G; Franceschi C
    Immunol Lett; 1990 May; 24(2):137-40. PubMed ID: 2141323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal fetal immunological development in Down's syndrome.
    Thilaganathan B; Tsakonas D; Nicolaides K
    Br J Obstet Gynaecol; 1993 Jan; 100(1):60-2. PubMed ID: 8427840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
    Aguilar P; Mathieu CP; Clerc G; Ethevenot G; Fajraoui M; Mattei S; Faure GC; Bene MC
    J Heart Lung Transplant; 2006 Feb; 25(2):200-5. PubMed ID: 16446221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT).
    Nagler A; Rabinowitz R; Rosengolts-Rat J; Condiotti R; Schlesinger M
    J Hematother Stem Cell Res; 2000 Feb; 9(1):63-75. PubMed ID: 10738973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-color flow cytometric analysis of preterm and term newborn lymphocytes.
    Juretić E; Uzarević B; Petrovecki M; Juretić A
    Immunobiology; 2000 Nov; 202(5):421-8. PubMed ID: 11205372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective natural killer cell activity of peripheral blood lymphocytes correlates with the degree of neutropenia in patients with chronic idiopathic neutropenia of adults.
    Papadaki HA; Coulocheri S; Xylouri I; Chatzivassili A; Konsolas J; Katrinakis G; Karkavitsas N; Eliopoulos GD
    Ann Hematol; 1998; 76(3-4):127-34. PubMed ID: 9619729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.